Danish professor to lead global efforts for coronamedicin

Right now trying researchers around the world to find a cure against corona virus.

Now the Danish professor Jens Lundgren lead a global effort, which will try to gather the knowledge and experience of many of the clinical trials, which will take place.

The inform University of Copenhagen, in a press release.

- We cooperate with 450 hospitals on all continents and expects to involve over 10,000 patients, so it is something of an effort, we have started with, " says Jens Lundgren.

The effort, as Jens Lundgren will be responsible get, called ACTIV-3.

the Effort is done in the way that it follows many different medicines effect on patients who are admitted to the hospital with coronavirus.

When a drug does not show preliminary signs of activity or have limiting side effects, as are studies of the product dropped, while the investigation is continuing for other funds, there also needs to be explored.

along the Way, researchers can make divisions among themselves as a part of the effort. On the way, the hope is to be able to accelerate the exploration of many drugs at one time.

- in the Past we have tested drugs that were already developed for other diseases. On the way, one can say that we have taken them down from the shelf to see if they could work.

- However, in this action, we must test a lot of different preparations, which are specifically designed against coronavirus. Therefore our aspirations, greater this time, explains Jens Lundgren.

He says that the process has started with the trials for the first product, and that there is the expectation to have preliminary results in september.

If they are good, will continue the experiments with the agent and potentially be able to find final clarification in the course of October or november.

the Exploration of at least three other products will commence in september.

Jens Lundgren is usually associated with the University of Copenhagen and Rigshospitalet as a professor.

Under the coronakrisen he has become a more known face to the general population, in that he has commented on the virus's development.